MELANOMA AND OTHER MALIGNANT NEOPLASMS OF SKIN
Clinical trials for MELANOMA AND OTHER MALIGNANT NEOPLASMS OF SKIN explained in plain language.
Never miss a new study
Get alerted when new MELANOMA AND OTHER MALIGNANT NEOPLASMS OF SKIN trials appear
Sign up with your email to follow new studies for MELANOMA AND OTHER MALIGNANT NEOPLASMS OF SKIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Drug attack on Tough-to-Treat skin cancer
Disease control OngoingThis study is testing whether adding an experimental pill called GSK2636771 to an approved immunotherapy drug (pembrolizumab) can help control advanced melanoma that has not responded to prior treatment and has a specific genetic feature called PTEN loss. The main goals are to fi…
Matched conditions: MELANOMA AND OTHER MALIGNANT NEOPLASMS OF SKIN
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 09, 2026 14:22 UTC
-
New combo aims to boost immune attack on tough melanoma
Disease control OngoingThis study is testing whether adding an oral drug called azacitidine to the immunotherapy pembrolizumab can help control advanced melanoma. It is for patients who are new to this type of immunotherapy or whose cancer has worsened despite it. The main goal is to see if the combina…
Matched conditions: MELANOMA AND OTHER MALIGNANT NEOPLASMS OF SKIN
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 03, 2026 14:07 UTC